Marian Reiff1, Christine Wade, Maria T Chao, Fredi Kronenberg, Linda F Cushman. 1. The Richard and Hinda Rosenthal Center for Complementary and Alternative Medicine Department of Rehabilitation Medicine, College Physicians & Surgeons, Columbia University, New York, New York, USA. reiff82@gmail.com
Abstract
BACKGROUND: Intravaginal topical microbicides are being investigated for prevention of HIV transmission. Use of vaginal microbicides will constitute a new type of practice, occurring in the context of other vaginal practices related to contraception, hygiene, and self-care, which are affected by cultural norms and personal beliefs. Given the high rate of HIV infection among black women, research on practices and decision making relevant to microbicide acceptability is needed in this population. METHODS: Twenty-three black women in New York City, aged 25-64, completed in-person semistructured interviews and self-administered questionnaires. Quantitative analyses examined vaginal practices and willingness to use microbicides. Qualitative analyses explored underlying decision-making processes involved in choices regarding vaginal practices and general healthcare. RESULTS: Willingness to use vaginal products for HIV prevention was high, especially among more educated women. Safety was a major concern, and women were cautious about using vaginal products. Whereas some viewed synthetic products as having potentially harmful side effects, others perceived natural products as risky because of insufficient testing. Choices about vaginal practices were affected by assessments of risk and efficacy, prior experience, cultural background, and general approach to healthcare. CONCLUSIONS: The majority of women in the sample expressed willingness to use a vaginal product for HIV prevention. Decision-making processes regarding vaginal practices were complex and were affected by social, cultural, and personal factors. Although specific preferences may vary, attitudes toward using a vaginal product are likely to be positive when side effects are minimal and the product is considered safe.
BACKGROUND: Intravaginal topical microbicides are being investigated for prevention of HIV transmission. Use of vaginal microbicides will constitute a new type of practice, occurring in the context of other vaginal practices related to contraception, hygiene, and self-care, which are affected by cultural norms and personal beliefs. Given the high rate of HIV infection among black women, research on practices and decision making relevant to microbicide acceptability is needed in this population. METHODS: Twenty-three black women in New York City, aged 25-64, completed in-person semistructured interviews and self-administered questionnaires. Quantitative analyses examined vaginal practices and willingness to use microbicides. Qualitative analyses explored underlying decision-making processes involved in choices regarding vaginal practices and general healthcare. RESULTS: Willingness to use vaginal products for HIV prevention was high, especially among more educated women. Safety was a major concern, and women were cautious about using vaginal products. Whereas some viewed synthetic products as having potentially harmful side effects, others perceived natural products as risky because of insufficient testing. Choices about vaginal practices were affected by assessments of risk and efficacy, prior experience, cultural background, and general approach to healthcare. CONCLUSIONS: The majority of women in the sample expressed willingness to use a vaginal product for HIV prevention. Decision-making processes regarding vaginal practices were complex and were affected by social, cultural, and personal factors. Although specific preferences may vary, attitudes toward using a vaginal product are likely to be positive when side effects are minimal and the product is considered safe.
Authors: Maria T Chao; Christine Wade; Fredi Kronenberg; Debra Kalmuss; Linda F Cushman Journal: J Altern Complement Med Date: 2006-10 Impact factor: 2.579
Authors: Dawn M Upchurch; Laura Chyu; Gail A Greendale; Jessica Utts; Yali A Bair; Guili Zhang; Ellen B Gold Journal: J Womens Health (Larchmt) Date: 2007 Jan-Feb Impact factor: 2.681
Authors: Jamila K Stockman; Jennifer L Syvertsen; Angela M Robertson; Natasha T Ludwig-Barron; Julie N Bergmann; Lawrence A Palinkas Journal: Womens Health Issues Date: 2014-05-14
Authors: Andrew Vallely; Lisa Fitzgerald; Voletta Fiya; Herick Aeno; Angela Kelly; Joyce Sauk; Martha Kupul; James Neo; John Millan; Peter Siba; John M Kaldor Journal: BMC Res Notes Date: 2012-11-01
Authors: Amy H Lin; Tiffany L Breger; Matthew Barnhart; Ann Kim; Charlotte Vangsgaard; Emily Harris Journal: J Int AIDS Soc Date: 2014-09-08 Impact factor: 5.396
Authors: Rachel J Primrose; Toral Zaveri; Alyssa J Bakke; Gregory R Ziegler; Howard R Moskowitz; John E Hayes Journal: PLoS One Date: 2016-03-21 Impact factor: 3.240
Authors: Toral Zaveri; Kimberly A Powell; Kate M Guthrie; Alyssa J Bakke; Gregory R Ziegler; John E Hayes Journal: BMC Womens Health Date: 2018-10-20 Impact factor: 2.809